These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 33554072

  • 1. Impact of liver-specific GLUT8 silencing on fructose-induced inflammation and omega oxidation.
    Novelle MG, Bravo SB, Deshons M, Iglesias C, García-Vence M, Annells R, da Silva Lima N, Nogueiras R, Fernández-Rojo MA, Diéguez C, Romero-Picó A.
    iScience; 2021 Feb 19; 24(2):102071. PubMed ID: 33554072
    [Abstract] [Full Text] [Related]

  • 2. Glucose transporter 8 (GLUT8) mediates fructose-induced de novo lipogenesis and macrosteatosis.
    DeBosch BJ, Chen Z, Saben JL, Finck BN, Moley KH.
    J Biol Chem; 2014 Apr 18; 289(16):10989-10998. PubMed ID: 24519932
    [Abstract] [Full Text] [Related]

  • 3. Crosstalk between TM4SF5 and GLUT8 regulates fructose metabolism in hepatic steatosis.
    Lee H, Kim E, Shin EA, Shon JC, Sun H, Kim JE, Jung JW, Lee H, Pinanga Y, Song DG, Liu KH, Lee JW.
    Mol Metab; 2022 Apr 18; 58():101451. PubMed ID: 35123128
    [Abstract] [Full Text] [Related]

  • 4. Comparative study of the modulation of fructose/sucrose-induced hepatic steatosis by mixed lipid formulations varying in unsaturated fatty acid content.
    Siddiqui RA, Xu Z, Harvey KA, Pavlina TM, Becker MJ, Zaloga GP.
    Nutr Metab (Lond); 2015 Apr 18; 12():41. PubMed ID: 26583036
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Does fructose consumption contribute to non-alcoholic fatty liver disease?
    Tappy L, Lê KA.
    Clin Res Hepatol Gastroenterol; 2012 Dec 18; 36(6):554-60. PubMed ID: 22795319
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Glucose transporter 8 (GLUT8) regulates enterocyte fructose transport and global mammalian fructose utilization.
    DeBosch BJ, Chi M, Moley KH.
    Endocrinology; 2012 Sep 18; 153(9):4181-91. PubMed ID: 22822162
    [Abstract] [Full Text] [Related]

  • 10. Kefir peptides prevent high-fructose corn syrup-induced non-alcoholic fatty liver disease in a murine model by modulation of inflammation and the JAK2 signaling pathway.
    Chen HL, Tsai TC, Tsai YC, Liao JW, Yen CC, Chen CM.
    Nutr Diabetes; 2016 Dec 12; 6(12):e237. PubMed ID: 27941940
    [Abstract] [Full Text] [Related]

  • 11. Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD).
    Alwahsh SM, Gebhardt R.
    Arch Toxicol; 2017 Apr 12; 91(4):1545-1563. PubMed ID: 27995280
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.
    Sun G, Jackson CV, Zimmerman K, Zhang LK, Finnearty CM, Sandusky GE, Zhang G, Peterson RG, Wang YJ.
    BMC Gastroenterol; 2019 Mar 18; 19(1):41. PubMed ID: 30885145
    [Abstract] [Full Text] [Related]

  • 15. Betaine prevented fructose-induced NAFLD by regulating LXRα/PPARα pathway and alleviating ER stress in rats.
    Ge CX, Yu R, Xu MX, Li PQ, Fan CY, Li JM, Kong LD.
    Eur J Pharmacol; 2016 Jan 05; 770():154-64. PubMed ID: 26593707
    [Abstract] [Full Text] [Related]

  • 16. n-3 Fatty acids combined with flavan-3-ols prevent steatosis and liver injury in a murine model of NAFLD.
    Vauzour D, Rodriguez-Ramiro I, Rushbrook S, Ipharraguerre IR, Bevan D, Davies S, Tejera N, Mena P, de Pascual-Teresa S, Del Rio D, Gavrilovic J, Minihane AM.
    Biochim Biophys Acta Mol Basis Dis; 2018 Jan 05; 1864(1):69-78. PubMed ID: 28986308
    [Abstract] [Full Text] [Related]

  • 17. Effects of Natural Products on Fructose-Induced Nonalcoholic Fatty Liver Disease (NAFLD).
    Chen Q, Wang T, Li J, Wang S, Qiu F, Yu H, Zhang Y, Wang T.
    Nutrients; 2017 Jan 31; 9(2):. PubMed ID: 28146130
    [Abstract] [Full Text] [Related]

  • 18. Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease.
    Leung C, Herath CB, Jia Z, Andrikopoulos S, Brown BE, Davies MJ, Rivera LR, Furness JB, Forbes JM, Angus PW.
    World J Gastroenterol; 2016 Sep 21; 22(35):8026-40. PubMed ID: 27672297
    [Abstract] [Full Text] [Related]

  • 19. Azoramide ameliorates fructose-induced nonalcoholic fatty liver disease in mice.
    Bagci R, Sahinturk V, Sahin E.
    Tissue Cell; 2019 Aug 21; 59():62-69. PubMed ID: 31383290
    [Abstract] [Full Text] [Related]

  • 20. Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD.
    Luo Y, Burrington CM, Graff EC, Zhang J, Judd RL, Suksaranjit P, Kaewpoowat Q, Davenport SK, O'Neill AM, Greene MW.
    Am J Physiol Endocrinol Metab; 2016 Mar 15; 310(6):E418-39. PubMed ID: 26670487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.